Evidence Hub

Sedative and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in puppies - randomised, blinded clinical trial

Vuokko I. E. Pekkola, Jaan Lepajõe, A. Kiviranta, Kati M. Salla, M. Raekallio, Ira J. Kallio-Kujala

Veterinary Anaesthesia and Analgesia, 2026

16 participants

Abstract

OBJECTIVE

To explore efficacy and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in healthy puppies.

STUDY DESIGN

Randomised, blinded clinical trial.

ANIMALS

A group of healthy client-owned puppies aged between 42 and 51 days scheduled for elective brainstem auditory-evoked response (BAER) testing.

METHODS

Puppies were randomised within each litter to the following two groups: MB (n = 16; medetomidine hydrochloride 10 μg kg-1 and butorphanol 0.2 mg kg-1) or MVB (n = 16; medetomidine hydrochloride 10 μg kg-1, vatinoxan hydrochloride 0.2 mg kg-1, and butorphanol 0.2 mg kg-1). Drugs were injected intramuscularly. Pulse rate (PR), arterial blood haemoglobin oxygen saturation (SpO2) and mean arterial blood pressure (MAP) were measured noninvasively every 5 minutes. Sedation depth was assessed with a multidimensional scoring system. Following BAER testing, sedation was reversed with intramuscular atipamezole hydrochloride 25 μg kg-1. Linear mixed models were created to investigate the effects of time and treatment group on PR and MAP.

RESULTS

All puppies were sufficiently sedated for BAER testing within 5 minutes after treatment. PR was significantly higher and MAP significantly lower with MVB than with MB 5 to 15 minutes after drug injection (p ≤ 0.001). PR nadir was detected at 5 minutes after both treatments (109 ± 15 beats minute-1 and 142 ± 28 beats minute-1 with MB and MVB, respectively). No hypotension (MAP < 60 mmHg) was detected in any…

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 16 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free